35 Healthcare Stocks Moving In Tuesday's Pre-Market Session

Gainers

• Stealth BioTherapeutics, Inc. MITO stock increased by 38.4% to $3.10 during Tuesday's pre-market session. According to the most recent rating by H.C. Wainwright, on December 23, the current rating is at Neutral.
• Viveve Medical, Inc. VIVE shares increased by 17.8% to $1.39. According to the most recent rating by Ladenburg Thalmann, on December 03, the current rating is at Buy.
• Brickell Biotech, Inc. BBI shares surged 17.2% to $1.36.
• InMode, Inc. INMD stock moved upwards by 7.1% to $47.10. The most recent rating by Roth Capital, on December 19, is at Buy, with a price target of $13.00.
• Aytu BioScience, Inc. AYTU shares increased by 6.2% to $0.84.
• CannTrust Holdings, Inc. CTST stock surged 5.7% to $0.87.
• Spectrum Pharmaceuticals, Inc. SPPI shares rose 5.7% to $2.99. The most recent rating by B. Riley FBR, on December 27, is at Buy, with a price target of $11.00.
• Seelos Therapeutics, Inc. SEEL shares surged 5.3% to $0.98.
• Ardelyx, Inc. ARDX shares rose 4.9% to $7.55. The most recent rating by Citigroup, on February 12, is at Buy, with a price target of $13.00.
• Inovio Pharmaceuticals, Inc. INO shares increased by 4.8% to $4.35. The most recent rating by PiperJaffray, on January 03, is at Overweight, with a price target of $8.00.
• Xeris Pharmaceuticals, Inc. XERS stock rose 4.5% to $4.18. The most recent rating by Piper Sandler, on February 18, is at Overweight, with a price target of $12.00.
• Genprex, Inc. GNPX stock surged 4.4% to $4.47.
• Aptevo Therapeutics, Inc. APVO stock increased by 4.2% to $0.50.
• Cellectar Biosciences, Inc. CLRB shares moved upwards by 4.1% to $3.05. The most recent rating by Roth Capital, on January 21, is at Buy, with a price target of $10.00.
• ADMA Biologics, Inc. ADMA shares rose 4.0% to $3.65.
• Moleculin Biotech, Inc. MBRX stock surged 3.9% to $0.79.
• TG Therapeutics, Inc. TGTX shares moved upwards by 3.9% to $16.40. The most recent rating by H.C. Wainwright, on January 17, is at Buy, with a price target of $24.00.
• BioXcel Therapeutics, Inc. BTAI shares increased by 3.6% to $38.30. The most recent rating by SunTrust Robinson Humphrey, on February 14, is at Buy, with a price target of $150.00.
• BioCryst Pharmaceuticals, Inc. BCRX shares moved upwards by 3.6% to $2.90.
• Mustang Bio, Inc. MBIO stock rose 3.5% to $3.89.
• Biogen, Inc. BIIB shares rose 3.3% to $344.00. The most recent rating by Nomura, on February 07, is at Buy, with a price target of $392.00.
• Bio-Path Holdings, Inc. BPTH stock surged 3.2% to $6.76. The most recent rating by H.C. Wainwright, on December 02, is at Buy, with a price target of $25.00.
• Novavax, Inc. NVAX stock moved upwards by 3.1% to $7.92.
• Oncolytics Biotech, Inc. ONCY stock increased by 3.1% to $2.67.
• SmileDirectClub, Inc. SDC shares moved upwards by 3.0% to $13.22. The most recent rating by Wolfe Research, on January 09, is at Underperform, with a price target of $7.00.

Losers

• Lianluo Smart, Inc. LLIT shares fell 5.0% to $0.96 during Tuesday's pre-market session.
• Avinger, Inc. AVGR stock fell 4.7% to $0.59.
• Bruker, Inc. BRKR shares plummeted 4.0% to $48.50. The most recent rating by Wells Fargo, on January 08, is at Overweight, with a price target of $60.00.
• Cleveland BioLabs, Inc. CBLI stock decreased by 3.9% to $2.00.
• Intec Pharma, Inc. NTEC shares decreased by 3.7% to $0.27.
• Sundial Growers, Inc. SNDL shares fell 3.7% to $1.30. According to the most recent rating by CIBC, on January 31, the current rating is at Underperformer.
• Agile Therapeutics, Inc. AGRX shares declined 3.7% to $3.92.
• HEXO, Inc. HEXO shares plummeted 3.3% to $1.46.
• VBI Vaccines, Inc. VBIV stock decreased by 3.3% to $1.48.
• Brainstorm Cell, Inc. BCLI shares declined 3.1% to $5.00.